Sitemap
June 07, 2008 Articles
Filter by Available Specialty
- ADVANCE: intensive glucose control reduced micro- and macrovascular disease together by 10%
- Combination sitagliptin/metformin improved beta-cell function, HbA1c at two years
- DIAD: Favorable 5-year outcome for asymptomatic patients with type 2 diabetes and no CAD history
- Dietary protein intake debated at ADA meeting
- From HbA1c to estimated average glucose: making life easier for patients, physicians
- Glycemic control, fasting plasma glucose improved with once-weekly exenatide
- LEAD 3: Liraglutide reduced blood glucose, weight, blood pressure in patients with type 2 diabetes
- Obesity is a driving factor for increased CVD risk among adolescents